Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components (Q40267468)

19 September 2017

Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components (English)

1 reference

19 September 2017

1 reference

Krystyna Mozdzanowska

1

1 reference

19 September 2017

Jingqi Feng

2

1 reference

19 September 2017

Mark Eid

3

1 reference

19 September 2017

Darya Zharikova

4

1 reference

19 September 2017

Walter Gerhard

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

14 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

352

1 reference

19 September 2017

2

1 reference

19 September 2017

418-426

1 reference

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Influenza virus entry and infection require host cell N-linked glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Neutralization of sensitized virus by the fourth component of complement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Fusion of influenza virus with the endosomal membrane is inhibited by monoclonal antibodies to defined epitopes on the hemagglutinin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

C1q content of serum and lung lavage fluid of rats exposed to toxic levels of oxygen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Mechanism of neutralization of influenza virus infectivity by antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Visualizing infection of individual influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Complement components required for virus neutralization by early immunoglobulin antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

The antiviral activity of antibodies in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Differential Requirements of Rab5 and Rab7 for Endocytosis of Influenza and Other Enveloped Viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Surfactant protein A regulates complement activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.05.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.05.008

1 reference

19 September 2017

1 reference